Fcrl2em1(cre/ERT2)Cya
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Fcrl2em1(cre/ERT2)Cya |
| Name: |
Fc receptor like 2; endonuclease-mediated mutation 1, Cyagen Biosciences |
| MGI ID: |
MGI:8235565 |
| Synonyms: |
Fcrlsem1(IRES-CreERT2-P2A-EGFP) |
| Gene: |
Fcrl2 Location: Chr3:87158318-87171046 bp, - strand Genetic Position: Chr3, 38.19 cM, cytoband F1
|
| Alliance: |
Fcrl2em1(cre/ERT2)Cya page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Fcrl2em1(cre/ERT2)Cya expression driven by
1 gene
Knock-in expression driven by:
|
| |
|
Mutation details: The IRES-CreERT2-P2A-EGFP-WPRE-BGH pA cassette was inserted 60~100bp downstream of the TGA stop codon. CreERT2 recombinase and enhanced green fluorescent protein (EGFP) are expressed under the regulatory control of the endogenous gene elements. This model is a Tamoxifen-inducible Cre mouse, and when crossed with allele containing loxP sites, the offspring allele are expected to undergo sequence recombination between loxP sites mediated by Cre recombinase in Fcrls-positive cells following Tamoxifen induction. In addition to studies of Cre recombinase-mediated gene recombination, this model can also be used for EGFP fluorescent protein tracing studies.
(J:326541)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Fcrl2
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Fcrl2 Mutation: |
41 strains or lines available
|
|
|
|
Analysis Tools
